BCRX financials
BioCryst (BCRX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
BCRX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $874.84M | $855.76M | $340.99M | $263.86M | 1.21 |
| 2024 | $450.71M | $438.23M | -$2.54M | -$88.88M | -0.43 |
| 2023 | $331.41M | $326.75M | -$103.71M | -$226.54M | -1.18 |
| 2022 | $270.83M | $264.23M | -$148.44M | -$247.12M | -1.33 |
| 2021 | $157.17M | $149.91M | -$177.72M | -$184.06M | -1.03 |
| 2020 | $17.81M | $16.14M | -$174.76M | -$182.81M | -1.09 |
- BCRX revenue was $874.84M in fiscal 2025, net income $263.86M.
Updated 2026-11-03 02:03 UTC